Discloses matters regarding the issuance of stock options. Includes items such as exercise period, number of shares allocated, issue price, and conditions for exercising, with emphasis on future issuance plans and potential shareholder impact. Specific amounts are not disclosed.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7096","jir_company_name":"Stem Cell Research Institute Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-08-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/7096-20260812-01.pdf","jir_short_summary":"Discloses matters regarding the issuance of stock options. Includes items such as exercise period, number of shares allocated, issue price, and conditions for exercising, with emphasis on future issuance plans and potential shareholder impact. Specific amounts are not disclosed.","jir_summary":"### Section Heading\nThis document discloses concrete details regarding the issuance of stock options. It lists the issuance purpose, issue date, number of allocated shares, exercise price, exercise period, and vesting conditions, and may explain the dilutive impact on shareholders and its position within the capital policy. For any unclear figures, please refer to the PDF.\n\n### Section 2 Heading\nWe anticipate further explanations on the issuance schedule and exercise conditions from a shareholder protection perspective. Additionally, the alignment of this stock option issuance with the company\u2019s growth strategy and talent incentives, as well as consistency with mid-to-long-term plans, will be important points.","jir_financial_highlights":"Number of stock options allocated: Unknown (Unknown)\nExercise period for stock options: From August 1, 2030 to July 31, 2032 (Unknown)\nTotal number of stock options issued: Unknown (Unknown)","jir_category":"","jir_hashtags":"#StemCellResearchInstituteNonDisclosed #StockOptions #StockOptions","jir_key_figures":"New stock options allocated: Unknown\nExercise period for stock options: August 1, 2030 \u2013 July 31, 2032\nTotal number of stock options issued: Unknown","jir_meta_title":"[Company Name] Notice Regarding Issuance of Stock Options | Issuance Period, etc.","jir_meta_description":"We announce issuance of stock options. Key points for investors, including allocated shares, issuance date, exercise period, and vesting conditions. Specific values are in the PDF.","jir_og_title":"[Company Name] Stock Options Issuance Notice","jir_og_description":"Details on the issuance of stock options. Exercise period is 2030\u20132032; allocated shares are unknown. Investors are advised to check the relevant sections in the PDF.","jir_og_image_url":"\/assets\/og\/company-stock_option.jpg","jir_chart_data_collection":"[]","ir_related_company":0,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-102947","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n